Showing 1281-1290 of 1635 results for "".
- Aqueous Humor Proteome Database Established by Medical College of Georgiahttps://modernod.com/news/aqueous-humor-proteome-database-established-by-medical-college-of-georgia/2482236/The National Eye Institute (NEI) recently announced a database that will enable researchers to better study causes of vision loss has been established by scientists at the Medical College of Georgia (MCG) at Augusta University in Augusta, Georgia. The Aqueous Humor (AH) Proteome Databas
- BlueRock Therapeutics and Foundation Fighting Blindness Partner for IRD Studyhttps://modernod.com/news/bluerock-therapeutics-and-foundation-fighting-blindness-partner-for-ird-study/2482178/BlueRock Therapeutics LP, a clinical stage cell therapy company and subsidiary of Bayer, and Foundation Fighting Blindness announced a collaboration to add a new cohort to the Foundation’s 'Uni-Rare natural history study' of people living with inherited retinal diseases (I
- Mice Sent to Space on SpaceX Rocket as Part of Oculogenex Gene Therapy Studyhttps://modernod.com/news/gene-therapy-company-oculogenex-set-to-launch-on-spacex-crs-30-today/2482175/Today’s scheduled launch of NASA’s SpaceX CRS-30 mission will carry more than 40 science payloads to the International Space Station for a new round of microgravity research. SpaceX CRS-30 is scheduled to launch today at 4:55 ET. The mission will include Oculogene
- Industry Opticianry Organizations Announce Merger at Vision Expo Easthttps://modernod.com/news/industry-opticianry-organizations-announce-merger-at-vision-expo-east/2482169/The Opticians Association of America [OAA], and the National Federation of Opticianry Schools [NFOS], have completed a merger to create the "United Opticians Association [UOA]," a model Opticianry Association representing over 80,000 opticians and contact lens professionals throughout N
- Neurolens Restructures Leadership Teamhttps://modernod.com/news/neurolens-restructures-leadership-team/2482165/Neurolens announced a strategic leadership restructure, which includes Davis Corley, co-founder, returning as CEO. Other leadership hires: Gregory Boisse, SVP of Operations Nathan Schomas, SVP of Digital Innovation
- Alcon Launches Clareon Presbyopia Correcting IOLs in Indiahttps://modernod.com/news/alcon-launches-clareon-presbyopia-correcting-iols-in-india/2482160/Alcon announced the launch of the Clareon family of IOLs in India. Clareon is designed to deliver consistent visual outcomes and exceptional clarity that lasts and is features a glistening-free IOL material that has among the lowest levels of haze and subsurface nanoglist
- Ocular Therapeutix Announces Board of Directors and Leadership Updateshttps://modernod.com/news/ocular-therapeutix-announces-board-of-directors-and-leadership-updates/2482128/Ocular Therapeutix announced Board of Directors and leadership updates with the addition of Pravin U. Dugel, MD as Executive Chairman; and the additions of Jeffrey S. Heier, MD, Peter K. Kaiser, MD, and Sanjay Nayak, MBBS, PhD, to the Ocular management
- Researchers Identify Genes and Cell Types That May Have Causal Role in POAG Formationhttps://modernod.com/news/researchers-identify-genes-and-cell-types-that-may-have-causal-role-in-poag-formation/2482119/In a new study published in Nature Communications, researchers from Mass Eye and Ear conducted a comprehensive study that combined genetic discoveries from a large cross-ancestry genome-wide association study meta-analysis of primary open-angle glaucoma (POAG), and a large
- New Penn Study Finds Promising Model for Restoring Cone Functionhttps://modernod.com/news/new-penn-study-finds-promising-model-for-restoring-cone-function/2482111/Vision scientists from the Division of Experimental Retinal Therapies at the University of Pennsylvania School of Veterinary Medicine used functional magnetic resonance imaging (fMRI) to assess brain responses to lights that stimulate only cone cells in dogs with naturally occurrin
- NIH: New Technique Enhances Quality Control of Lab-Grown Cells for AMD Treatmenthttps://modernod.com/news/nih-new-technique-enhances-quality-control-of-lab-grown-cells-for-amd-treatment/2482074/Researchers at the National Eye Institute (NEI) say they have improved a crucial step in the production of retinal pigment epithelium (RPE) they are testing in a clinical trial as treatment for age-related macular degeneration (AMD). Their technique combines electrochemical cell measurements